As more treatment options become available, payers must make rational and informed decisions about how to best allocate resources towards a growing number of treatments.
As resources become more constrained, and the number of patients with diseases continues to increase, decisions on which drug to pay for become increasingly challenging. Payers must regularly choose between multiple treatment options. Most payers have formal processes to determine whether a drug represents good value.
To measure value, payers evaluate all types of data that reveal costs, as well as the outcomes, of a drug treatment.